TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
Rachel Hesler, Gerard C. Blobe(Duke University Hospital)
Cited by 106
Related Papers
The type III TGF-β receptor suppresses breast cancer progression
|Journal of Clinical Investigation|2006|255
ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration
|Carcinogenesis|2009|70